Astellas Pharma
While working for Fujisawa Pharmaceutical Company in the 1980s (Astellas Pharma today), Kino and his colleagues found that FK-506 (now called "tacrolimus"), which is produced by the soil bacterium "Streptomyces tsukubaensisis", could be expected to be an immunosuppressive drug.